BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18265668)

  • 1. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience.
    Mambrini A; Sanguinetti F; Pacetti P; Caudana R; Iacono C; Guglielmi A; Guadagni S; Del Freo A; Fiorentini G; Cantore M
    In Vivo; 2006; 20(6A):751-5. PubMed ID: 17203761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy.
    Mambrini A; Bassi C; Pacetti P; Torri T; Iacono C; Ballardini M; Orlandi M; Guadagni S; Fiorentini G; Cantore M
    Pancreas; 2008 Jan; 36(1):56-60. PubMed ID: 18192882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
    Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
    Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional chemotherapy for advanced pancreatic carcinoma.
    Bayar S; Unal E; Tez M; Kocaoglu H; Demirci S; Akgul H
    Hepatogastroenterology; 2003; 50(50):550-2. PubMed ID: 12749270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.
    Papachristou E; Link KH; Schoenberg MH
    Anticancer Res; 2003; 23(2A):831-4. PubMed ID: 12820308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
    Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
    Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
    Beger HG; Link KH; Gansauge F
    Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
    Maiello E; Gebbia V; Giuliani F; Testa A; Giotta F; Gebbia N; Colucci G
    Clin Ter; 1998; 149(5):351-5. PubMed ID: 10052247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional chemotherapy in advanced pancreatic carcinoma].
    Gansauge F; Link KH; Rilinger N; Kunz R; Beger HG
    Med Klin (Munich); 1995 Sep; 90(9):501-5. PubMed ID: 7476726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer.
    Pacetti P; Mambrini A; Paolucci R; Sanguinetti F; Palmieri B; Della Seta R; Muttini MP; Fiorentini G; Cantore M
    In Vivo; 2006; 20(6A):761-4. PubMed ID: 17203763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.
    Cantore M; Serio G; Pederzoli P; Mambrini A; Iacono C; Pulica C; Capelli P; Lombardi M; Torri T; Pacetti P; Pagani M; Fiorentini G
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):504-8. PubMed ID: 16633830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
    Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.
    Barletta E; Fiore F; Daniele B; Ottaiano A; D'Angelo R; Ferrari E; Formato R; Tortoriello A; Turitto G; Bruni GS; Pignata S; Iaffaioli RV
    Front Biosci; 2006 Jan; 11():782-7. PubMed ID: 16146770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.
    Kanayama M; Nagai H; Sumino Y
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.